
|Videos|October 24, 2015
Controlled Substance Red Flags
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
Advertisement
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
This video was recorded at the 2015 NCPA Annual Convention.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
2
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
3
What the Peptide Vote Actually Changes at My Counter (Hint: Not Much, Yet)
4
Ensitrelvir Approved for Postexposure Prophylaxis of COVID-19
5











































































































